Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.
| Traded as | Nasdaq: INDV |
|---|---|
| ISIN | USG4766E1168 |
| CIK | 0001625297 |
| LEI | 213800V3NCQTY7IED471 |
| EIN | 412520873 |
| Sector | Pharmaceutical |
|---|---|
| Industry | Pharmaceutical Preparations |
| CEO | — |
| Employees | — |
| Fiscal Year End | 0123 |
| Address | 10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD, VA, 23235 |
|---|---|
| Phone | 804-379-1090 |
| Website | https://indivior.com/ |
Get over a decade of historical stock quotes data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| INDV | Indivior Pharmaceuticals, Inc. | 2026-02-17 19:54:11 | 35.43 | 0.68 | 1.96 |
Get over a decade of historical company information data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INDV | 0001625297 | Indivior Pharmaceuticals, Inc. | USG4766E1168 | 213800V3NCQTY7IED471 | 412520873 | Nasdaq | 2834 | Pharmaceutical Preparations | 0123 | DE | 10710 MIDLOTHIAN TURNPIKE | NORTH CHESTERFIELD | VA | 23235 | UNITED STATES | US | 804-379-1090 | 10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD, VA, 23235 | 10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD, VA, 23235 | INDIVIOR PLC | Pharmaceutical | 1994 | — | — | https://indivior.com/ | 2,150,000,000 | 125,000,000 | 124,853,897 | Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. | 2026-02-12 16:46:24 |
Get over a decade of historical stock price data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
Get over a decade of historical stock price data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
Get over a decade of historical market cap data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 2,150,000,000 | 2,150,000,000 | 100 | 124,655,858 | 124,655,858 | 100 |
Get over a decade of historical employee count data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 1,051 |
Get over a decade of historical income statement data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
| Fiscal Year | 2024 |
|---|---|
| Revenue | 1,188,000,000 |
| Cost Of Revenue | 231,000,000 |
| Gross Profit | 957,000,000 |
| Research And Development Expenses | 107,000,000 |
| General And Administrative Expenses | 618,000,000 |
| Operating Expenses | 925,000,000 |
| Operating Income | 32,000,000 |
| Net Income | 2,000,000 |
| Earnings Per Share Basic | 0.02 |
| Earnings Per Share Diluted | 0.02 |
| Weighted Average Shares Outstanding Basic | 132,000,000 |
| Weighted Average Shares Outstanding Diluted | 133,000,000 |
Get over a decade of historical balance sheet statement data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
| Fiscal Year | 2024 |
|---|---|
| Cash And Cash Equivalents | 319,000,000 |
| Marketable Securities Current | 17,000,000 |
| Accounts Receivable | 254,000,000 |
| Inventories | 178,000,000 |
| Non Trade Receivables | 34,000,000 |
| Other Assets Current | 16,000,000 |
| Total Assets Current | 839,000,000 |
| Marketable Securities Non Current | 27,000,000 |
| Property Plant And Equipment | 100,000,000 |
| Other Assets Non Current | 29,000,000 |
| Total Assets Non Current | 139,000,000 |
| Total Assets | 1,319,000,000 |
| Accounts Payable | 63,000,000 |
| Deferred Revenue | — |
| Short Term Debt | 18,000,000 |
| Other Liabilities Current | 11,000,000 |
| Total Liabilities Current | 939,000,000 |
| Long Term Debt | 315,000,000 |
| Other Liabilities Non Current | 18,000,000 |
| Total Liabilities Non Current | 729,000,000 |
| Total Liabilities | 1,668,000,000 |
| Common Stock | 62,000,000 |
| Retained Earnings | -454,000,000 |
| Accumulated Other Comprehensive Income | -36,000,000 |
| Total Shareholders Equity | -348,000,000 |
Get over a decade of historical cash flow statement data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
| Fiscal Year | 2024 |
|---|---|
| Depreciation And Amortization | 29,000,000 |
| Share Based Compensation Expense | 24,000,000 |
| Other Non Cash Income Expense | — |
| Change In Accounts Receivable | 1,000,000 |
| Change In Inventories | 45,000,000 |
| Change In Non Trade Receivables | — |
| Change In Other Assets | -378,000,000 |
| Change In Accounts Payable | — |
| Change In Other Liabilities | 14,000,000 |
| Cash From Operating Activities | 36,000,000 |
| Purchases Of Marketable Securities | — |
| Sales Of Marketable Securities | — |
| Acquisition Of Property Plant And Equipment | 29,000,000 |
| Acquisition Of Business | 0 |
| Other Investing Activities | 0 |
| Cash From Investing Activities | 69,000,000 |
| Tax Withholding For Share Based Compensation | 22,000,000 |
| Payments Of Dividends | — |
| Issuance Of Common Stock | 3,000,000 |
| Repurchase Of Common Stock | 173,000,000 |
| Issuance Of Long Term Debt | 332,000,000 |
| Repayment Of Long Term Debt | 240,000,000 |
| Other Financing Activities | -2,000,000 |
| Cash From Financing Activities | -102,000,000 |
| Change In Cash | -27,000,000 |
| Cash At End Of Period | 319,000,000 |
| Income Taxes Paid | 46,000,000 |
| Interest Paid | 32,000,000 |
Get over a decade of historical insider transactions data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Anderson Woodrow D | Chief Accounting Officer | 2026-02-10 | 6,903 | A | 11,293 |
| Ciaffoni Joseph | Director, Chief Executive Officer | 2026-02-10 | 79,976 | A | 135,976 |
| Barry Patrick A | Chief Commercial Officer | 2026-02-10 | 31,380 | A | 31,380 |
| Heidbreder Christian | Chief Scientific Officer | 2026-02-10 | 33,622 | A | 190,762 |
| Burris Jeffrey W | Chief Legal Officer | 2026-02-10 | 26,897 | A | 27,657 |
Get over a decade of historical institutional holdings data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Madison Avenue Partners, LP | 2025-12-31 | 225,344,412 | 6,280,502 | 35.88 |
| Driehaus Capital Management LLC | 2025-12-31 | 71,772,163 | 2,000,339 | 35.88 |
| AWM Investment Company, Inc. | 2025-12-31 | 2,712,707 | 75,605 | 35.88 |
| Arax Advisory Partners | 2025-12-31 | 753 | 21 | 35.8571 |
| GLOBEFLEX CAPITAL L P | 2025-12-31 | 1,086,446 | 30,280 | 35.88 |
Get over a decade of historical mutual fund holdings data and access to complete datasets. Unlock API access, unlimited Excel and CSV downloads, and exclusive data collections, all available with a paid subscription.
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| EMPOWER FUNDS, INC. | 2025-12-31 | Institutional Class | MXERX | 93,088 | 3,339,997.5 | 0.3005 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Class L | MXNSX | 93,088 | 3,339,997.5 | 0.3005 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Investor Class | MXISX | 93,088 | 3,339,997.5 | 0.3005 |
| AMERICAN CENTURY ETF TRUST | 2025-11-30 | Avantis International Equity ETF | AVDE | 131,149 | 4,406,608.35 | 0.0401 |
| AMERICAN CENTURY ETF TRUST | 2025-11-30 | G Class | AVDNX | 3,418 | 114,844.85 | 0.0227 |
